A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...
The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback